NDC 16729-477 Regadenoson
Injection, Solution Intravenous
NDC Code 16729-477-31
Package Description: 5 mL in 1 SYRINGE, GLASS
What is NDC 16729-477?
The NDC code 16729-477 is assigned by the FDA to the product Regadenoson which is a human prescription drug product labeled by Accord Healthcare Inc.. The product's dosage form is injection, solution and is administered via intravenous form. The product is distributed in a single package with assigned NDC code 16729-477-31 5 ml in 1 syringe, glass . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.
What are Regadenoson Active Ingredients?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
Which are the Pharmacologic Classes for Regadenoson?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
* Please review the disclaimer below.